On April 23, 2026, as we discussed in our prior client alert, the Department of Justice issued a Final Order immediately placing cannabis “subject to a state medical marijuana license” in Schedule III of the Controlled Substances Act. The Order also directed the DEA to restart formal administrative rulemaking proceedings to consider the broader rescheduling of all cannabis from Schedule I to Schedule III. As we noted, the immediate practical implications were significant.
In the days since that announcement, several important developments have followed from the federal government, as outlined below.
Publication in the Federal Register
On April 27, 2026, three documents related to the rescheduling appeared on the Federal Register's public inspection page, with formal publication scheduled for April 28, 2026. Under the Final Order, the effective date of the rescheduling is the date of publication in the Federal Register — i.e., April 28, 2026. Publication also triggers certain